Ryman Healthcare Limited
RHCGF
$1.44
$0.22518.60%
OTC PK
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 6.69% | 8.92% | 10.42% | 11.89% | 13.47% |
| Total Other Revenue | 19.26% | 24.81% | 30.02% | 44.90% | 69.39% |
| Total Revenue | 7.37% | 9.76% | 11.44% | 13.37% | 15.53% |
| Cost of Revenue | 2.51% | 16.75% | 33.20% | 30.85% | 28.21% |
| Gross Profit | 136.49% | -169.35% | -158.56% | -159.46% | -159.95% |
| SG&A Expenses | -- | -- | -- | -- | -- |
| Depreciation & Amortization | 2.70% | 17.62% | 35.13% | 26.98% | 18.74% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 2.52% | 16.80% | 33.31% | 30.61% | 27.59% |
| Operating Income | 45.10% | -305.20% | -353.28% | -522.16% | -5,093.86% |
| Income Before Tax | 30.06% | -164.25% | -304.12% | -259.49% | -231.07% |
| Income Tax Expenses | 290.62% | 198.01% | 122.61% | 58.18% | -117.43% |
| Earnings from Continuing Operations | -143.96% | -879.29% | -203.76% | -184.11% | -163.30% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -143.96% | -879.29% | -203.76% | -184.11% | -163.30% |
| EBIT | 45.10% | -305.20% | -353.28% | -522.16% | -5,093.86% |
| EBITDA | 89.41% | -397.24% | -198.09% | -215.34% | -254.88% |
| EPS Basic | -125.47% | -710.76% | -196.59% | -169.22% | -146.74% |
| Normalized Basic EPS | -32.84% | -3.21% | 14.53% | 32.65% | 48.16% |
| EPS Diluted | -125.79% | -713.53% | -196.92% | -169.36% | -146.77% |
| Normalized Diluted EPS | -32.84% | -3.21% | 14.53% | 32.65% | 48.16% |
| Average Basic Shares Outstanding | 3.28% | 7.71% | 12.70% | 22.09% | 33.18% |
| Average Diluted Shares Outstanding | 3.28% | 7.71% | 12.70% | 22.09% | 33.18% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |